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The F plasmid PifA protein, known to be the cause of F exclusion of bacteriophage T7, is shown to be a membrane-associated protein. No
transmembrane domains of PifA were located. In contrast, T7 gp1.2 and gp10, the two phage proteins that trigger phage exclusion, are both
soluble cytoplasmic proteins. The Escherichia coli FxsA protein, which, at higher concentrations than found in wild-type cells, protects T7
from exclusion, is shown to interact with PifA. FxsA is a polytopic membrane protein with four transmembrane segments and a long
cytoplasmic C-terminal tail. This tail is not important in alleviating F exclusion and can be deleted; in contrast, the fourth transmembrane
segment of FxsA is critical in allowing wild-type T7 to grow in the presence of F PifA. These data suggest that the primary event that triggers
the exclusion process occurs at the cytoplasmic membrane and that FxsA sequesters PifA so that membrane damage is minimized.
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+Introduction
F exclusion of T7 is but one of many instances known
where a resident plasmid or prophage interferes with the
growth of a (super)infecting phage (for reviews, see Coffey
and Ross, 2002; Duckworth et al., 1981; Molineux, 1991;
Snyder, 1995; Snyder and Kaufmann, 1994). Exclusion may
manifest at many stages of the phage developmental cycle,
including adsorption to the host cell, genome penetration of
the cell cytoplasm, susceptibility of the phage genome to
endogenous restriction nucleases, and intracellular phage
gene expression. Exclusion through a block in adsorption
was originally called lysogenic conversion, a prophage gene
expressed in lysogenic state modifies or makes the cell
surface receptor inaccessible for the excluded phage; lyso-
genic conversion can thus alter the serotype of a bacterium.
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02115.temperate phages, the exclusion of T4 rII mutants by Erex
lysogens was one of the first abortive infections to be
described. Like T7 and F, and the exclusion of T5 by a
resident Col Ib plasmid, the underlying mechanism of rex
exclusion remains obscure. The plethora of physiological
defects that accompany these classic abortive infections has
made it difficult to distinguish the initial events that cause
the abortive infection from resulting later events.
Growth of bacteriophage T7 in Escherichia coli strains
harboring the F plasmid is aborted midway through
the infection cycle. The initial steps of infection occur
normally, and early gene products are synthesized just as
in a productive infection (Molineux, 1991). However, later
events are grossly abnormal. Transcription, particularly over
the late region of the T7 genome, is severely reduced (Britton
and Haselkorn, 1975; Condit and Steitz, 1975; Young and
Menard, 1975; Beck and Molineux, 1991). Inhibition is due
both to a decreasing capacity of the abortively infected cell to
sustain macromolecular synthesis and to the fact that only
about half of the infecting phage particles translocate the late
region of the genome into F cells (Garcia and Molineux,
1995). In addition, there is little or no phage DNA replication
and the host chromosome is not extensively degraded. ATP
and other small molecules leak from abortively infected cells
into the surrounding growth medium (Schmitt et al., 1991).
Although they do not lyse, the abortively infected cells die.
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is described as F exclusion.
A single F gene, pifA, is responsible for exclusion of T7
(Cram et al., 1984a, 1984b; Morrison and Malamy, 1971;
Schmitt and Molineux, 1991); early reports of a pifB gene
are erroneous. Expression of pifA is, however, controlled by
the operon repressor pifC (Kennedy et al., 1988; Miller and
Malamy, 1983, 1984). The pif operon is totally dispensable
for normal F plasmid maintenance and conjugation. Plas-
mids expressing pifA as the only F gene exclude T7 (Cram
et al., 1984a, 1984b; Schmitt and Molineux, 1991), and this
is the only known function of PifA. No biochemical
properties of PifA have been identified and its cellular
location is unknown.
Synthesis of either wild-type gp1.2 or gp10 of T7 is
required for F exclusion (Molineux et al., 1989). T7 mutants
that grow normally in male strains of E. coli necessarily
contain a null or missense mutation in gene 1.2 and two
missense mutations in gene 10. Genetic analyses suggest
that the gene 1.2 mutation and one of the gene 10mutations
both reduce interactions with pifA (Schmitt et al., 1991). The
second gene 10 mutation reduces the rate of synthesis of
gp10, thereby allowing sufficient progress through the
phage developmental cycle so that the exclusion process
no longer prevents production of progeny phage (Molineux
et al., 1989; Condreay and Molineux, 1989).
Gene 1.2 is not essential for phage growth in wild-type E.
coli strains, but is required for growth in optA mutants that
overproduce a cellular dGTPase (dgt) (Beauchamp and
Richardson, 1988; Saito and Richardson, 1981; Wurgler
and Richardson, 1990). Binding of gp1.2 to the dGTPase
inhibits its activity, and the enzyme is converted into an
rGTP-binding protein (Huber et al., 1988; Nakai and
Richardson, 1990). However, it is not clear whether this
activity of gp1.2 is pertinent to the process of F exclusion.
Mutations affecting the related T3 gene 1.2, which is
normally responsible for the ability of wild-type T3 to avoid
F exclusion, have been characterized that fail to inhibit dgt
but remain active in preventing exclusion, and vice versa
(Schmitt et al., 1987). Gene 10 codes for the major capsid
protein of T7; assembly of gp10 into proheads is not
required to elicit F exclusion (Condreay and Molineux,
1989), and no other activity of the protein has yet been
described.
All the physiological defects associated with the abortive
infection of T7 in F cells are found when plasmids contain-
ing either of T7 gene 1.2 or gene 10 as the only T7 gene are
expressed in cells containing pifA as the only F gene
(Schmitt, 1989; Schmitt and Molineux, 1991; Schmitt
et al., 1991). However, this simplification of the abortive
phage infection neither revealed the underlying mechanism
of exclusion, nor has it clearly identified the initial event
that results in the subsequent complex series of physiolo-
gical dysfunctions. Furthermore, neither the use of T7
mutants that grow in F cells nor the use of E. coli mutants
(containing a wild-type F) that exclude T7 growth todifferent degrees has yet distinguished the primary cause
from subsequent effects in the exclusion pathway. For
example, T7 mutants that escape F exclusion still cause
nucleotide leakage from infected cells, and E. coli mutants
that suppress F exclusion do not completely prevent leaki-
ness (Schmitt et al., 1991; Wang et al., 1999a, 1999b). The
loss of membrane integrity that allows small molecules to be
lost from the infected cell is therefore only an effect caused
by an earlier dysfunction.
An E. coli mutant that allows T7 to plate at normal
efficiency in the presence of F was isolated by selecting
cells that survived co-expression of gene 10A and pifA or
gene 1.2 and pifA (Wang et al., 1999a). The mutant contains
an up-mutation in the promoter for fxsA that causes 25-fold
overexpression of fxsA. The resulting increased synthesis of
FxsA alleviates the inhibition of T7 growth by F. Fluores-
cence microscopy of cells harboring fusions of fxsA to gfp
showed that FxsA-GFP was localized to the cell envelope
and the protein fractionated with the cytoplasmic membrane
(Wang et al., 1999b). The cellular function of FxsA is not
known and fxsA null mutants have no obvious phenotype.
To gain a better understanding of F exclusion and in
particular of how FxsA suppresses the abortive infection
of T7, we have determined the cellular locations of the
proteins involved. PifA is associated with the cytoplasmic
membrane, whereas gp1.2 and gp10 are both cytoplasmic
proteins. We show that PifA interacts with FxsA, suggesting
that the mechanism of protection by FxsA is to sequester
PifA from T7 gp1.2 and gp10. We have also determined the
membrane topology of FxsA, showing that it contains four
transmembrane segments and that the fourth segment, but
not the C-terminal cytoplasmic tail, is essential for suppress-
ing F exclusion.Results
PifA is associated with the cytoplasmic membrane
Overexpression of fxsA in cells containing F alleviates
exclusion of T7 (Wang et al., 1999a, 1999b). In those
studies, FxsA was shown to be a membrane-associated
protein, and it was therefore of interest to determine the
cellular location of the protein that causes exclusion. Cells
expressing pifA from its natural location on F were fractiona-
ted into cytoplasmic and membrane fractions. PifA protein
was visualized using anti-PifA antibody and was found
exclusively in the membrane fraction (Fig. 1A). Treatment
of this membrane fraction with 0.5% Sarkosyl resulted in the
complete solubilization of PifA (Fig. 1B). As Sarkosyl
selectively solubilizes cytoplasmic membrane proteins (Filip
et al., 1973), this result strongly suggests that PifA is tightly
bound to the cytoplasmic membrane. Washing with 1 M
NaCl does not cause PifA to dissociate from the membrane
(Fig. 1C), indicating that the protein is not simply associated
with the membrane through ionic interactions.
Fig. 2. Sensitivity of PifA to proteinase K in spheroplasts and inverted
membrane vesicles. After SDS-PAGE and electrophoretic transfer to a
membrane, His-PifA was detected using polyclonal anti-PifA antibodies.
Fig. 1. Association of PifAwith the cytoplasmic membrane. A. A crude cell
extract of E. coli IJ511/FVlac was separated into soluble (S) and membrane
(M) fractions, after SDS-PAGE PifA was detected after immunoblotting
using anti-PifA antibodies. B. The membrane fraction in A was extracted
with Sarkosyl; S: soluble; I: insoluble. C. The membrane fraction in A was
extracted with 1M NaCl; S: soluble; M: membrane proteins. D. Crude
membrane fractions of IJ511/FVlac were separated into outer and
cytoplasmic membranes by sucrose density gradient centrifugation.
Fractions were assayed for protein content (E) and NAH oxidase activity
(.). Proteins in gradient fractions were also separated by SDS-PAGE. PifA
and the outer membrane protein OmpA were determined by immunoblot-
ting using antibodies to PifA and OmpA. E. E. coli Top10 cells containing
the plasmids pGX31 (pifA-K59A), pGX26 (pifA-D[1–180]), or pGX25
(pifA-D[1–426]) were fractionated into membrane and soluble fractions as
in A. Each lane of A, B, C, and E contained 50 Ag of protein.
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outer membrane fractions through a 25–55% sucrose step
gradient (Osborn et al., 1972). Two distinct peaks of protein
were found (Fig. 1D); as expected OmpA, an outer mem-
brane marker, was detected in the heavy fractions, whereas
NADH oxidase, a cytoplasmic membrane protein, was
found in light fractions. The presence of PifA coincidedwith the inner membrane fractions, showing directly that
PifA is associated with the inner membrane.
Analysis of the predicted amino acid sequence of PifA
reveals a Walker A box or P-loop, a flexible loop commonly
associated with ATP/GTP-binding proteins (Koonin, 1993).
A site-specific mutation altering the conserved lysine of the
P-loop motif to alanine, yielding PifA-K59A, completely
abolishes activity with respect to exclusion of T7 (Wang,
1997). Cell extracts containing this mutant PifA were also
fractionated into membrane and soluble fractions, PifA-
K59A remained membrane-associated (Fig. 1E). Two N-
terminal deletions of PifA, neither of which interfered with
T7 growth, were also examined by this procedure. Removal
of the N-terminal 180 amino acids of PifA caused no change
in its membrane localization, whereas removal of the N-
terminal 462 amino acids (from a total of 717) resulted in a
distribution of PifA with about 60% in the membrane and
40% in the soluble fractions. Thus, amino acids 181–462 of
PifA contain a membrane-localization sequence with a
second determinant in the C-terminal third of the protein.
We then attempted a protease accessibility assay of PifA in
spheroplasts and inverted membrane vesicles prepared from
F cells. However, insufficient PifA is made from the single-
copy F plasmid for reproducible detection of the protein in
subcellular fractions. We therefore performed these studies
using cells expressing a multi-copy plasmid-borne N-termi-
nal-tagged variant of pifA, his-pifA. Plasmids expressing his-
pifA are as effective as comparable pifA plasmids in causing
exclusion of T7 (data not shown). After proteinase K treat-
ment of spheroplasts, anti-PifA antibody detected four dis-
tinct species (Fig. 2). The predominant protein has an
apparent mass that corresponds to intact his-PifA (83 kDa),
the minor bands have apparent mass values of approximately
75, 50, and 45 kDa. The 83- and 45-kDa species have the
same electrophoretic mobility as proteins detected by anti-his
antibody (data not shown), the two other bands have presum-
ably lost their N-termini. It is unclear how these fragments of
Fig. 3. Localization of T7 gp10A and gp1.2. Cell extracts of IJ1199
containing pQ and pWSK10A (A), or pQ and pAK25 (B), were separated
into membrane and soluble fractions, and proteins were resolved by SDS-
PAGE. A. Gp10A and FxsA were detected by immunoblotting using anti-
gp10A and anti-FxsA serum. B. Gp1.2 and FxsA were detected by
immunoblotting using anti-gp1.2 and anti-FxsA serum. Each lane contained
25 Ag of protein.
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overexpression. Protease treatment of inverted membrane
vesicles destroyed almost all protein cross-reacting with
anti-PifA antibodies, the small amounts of residual material
are likely to be due to vesicles that did not invert. Overall,
these data suggest that PifA is a cytoplasmic, membrane-
bound protein, but it may exist inmore than one conformation
when present at artificially high concentrations.
In an attempt to determine whether PifA is a transmem-
brane protein containing periplasmic domains, we selected
TnphoA insertions into different pifA plasmids, and in
several experiments examined more than 5000 independent
colonies. Only 10 colonies were blue on XP indicator pla-
tes, indicative of a periplasmic location of a PhoA fusion
protein, but none contained a pifA-phoA fusion. Eight of the
10 colonies contained a plasmid where TnphoA had
inserted—at more than one site—into bla, the gene for
ampicillin resistance. Because plasmid maintenance and cell
growth required h-lactamase, and therefore that Bla–PhoA
fusion proteins maintain catalytically active, we believe that
this screen for pifA-phoA fusions was quite rigorous. How-
ever, we failed to find blue colonies in a separate experiment
where the target plasmid for TnphoA transposition contained
both pifA and fxsA. Fusions of PhoA to the short periplasmic
domains of FxsA (see Fig. 5, below) would yield blue
colonies. This negative result left open the possibility that
PifA might also contain a short periplasmic domain(s). We
constructed four pifA-phoA fusions in vitro using convenient
restriction sites corresponding to pifA codons 121, 175, 275,
and 520 (full-length PifA contains 717 amino acids). Using
synthetic oligonucleotides, an additional eight fusions were
constructed within a 50 amino acid region (residues 332
through 381) of PifA that, from the protease accessibility of
PifA in spheroplasts, was thought most likely to contain the
putative transmembrane segment of PifA. No fusion yielded
blue colonies on indicator plates, suggesting that fusions of
PhoA to a periplasmic domain of PifA are lethal to E. coli or
are rapidly degraded or that PifA is not a transmembrane
protein and thus has no periplasmic domains. Although no
firm conclusions about a periplasmic domain(s) of PifA can
be drawn from this work, we remain certain that PifA is a
membrane-associated protein.
T7 gp10A and gp1.2 are both cytoplasmic proteins
Indirect evidence has suggested that PifA interacts di-
rectly with both T7 gp1.2 and gp10A (Molineux, 1991;
Wang et al., 1999a, 1999b). Because PifA is membrane-
associated, it was therefore of interest to determine the
cellular location of the two T7 proteins. To address this
question, cell extracts were fractionated by SDS-PAGE and
probed with anti-gp10A and anti-gp1.2 serum. To minimize
aggregation or inclusion body formation of gp10A due to its
low solubility (Cerritelli and Studier, 1996), gp10A was
expressed from a low copy number plasmid without induc-
tion. T7 gp1.2 is known to be a soluble protein (Myers et al.,1987). Cells containing either T7 gp10A or gp1.2 were
lysed and extracts separated into membrane and soluble
fractions. Under conditions where FxsA was exclusively
found in the membrane fraction, both gp10A and gp1.2
were found only in the soluble fraction (Fig. 3). Over-
expression of T7 gene 10A in cells resulted in 15–20% of
gp10A fractionating with the membrane (data not shown).
This association was weak and could be abolished by the
addition of 0.1 M NaCl to the cell extract before fraction-
ation. Moderate concentrations of NaCl are optimal for
gp10A solubility (Cerritelli and Studier, 1996), and the
apparent mislocalization to the membrane is likely an
artifact of high intracellular concentrations. We conclude
that both T7 gp1.2 and gp10 are normally cytoplasmic
proteins, although during F exclusion of T7, they likely
interact with the membrane-associated protein PifA (X. C.
and I. J. M., unpublished data).
The N- and C-termini of FxsA are both cytoplasmic
In a previous study, FxsAwas shown to be a cytoplasmic
membrane protein that, when present at elevated levels,
allowed T7 to avoid F exclusion (Wang et al., 1999a,
1999b). Most computer algorithms that predict membrane
   
       
 
      
  
         
Fig. 4. Both the N- and C-termini of FxsA face the cytoplasm. Spheroplasts
and inverted membrane vesicles (IMV) were treated with Proteinase K,
with or without detergent, for various times. Samples were subjected to
SDS-PAGE and analyzed by immunoblotting using antibodies against a his-
tag, the C-terminal 37 residues of E. coli FxsA, the outer membrane protein
OmpA, or the cytoplasmic protein thioredoxin.
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brane domains with the N-terminus of the protein in the
cytoplasm and the hydrophilic C-terminal tail in the peri-
plasm. We began to determine the actual topology by
constructing the plasmid pHisFxsA, which directs synthesis
of an N-terminal His-tagged variant of FxsA. This plasmid
allows T7 to grow in strains containing F (see Table 1,
below); the his-tag does not therefore interfere with FxsA
activity. Consequently, it is unlikely that the positively
charged his-tag significantly alters the membrane topology
of the native protein.
Cells containing pHisFxsA were converted into either
spheroplasts or inverted membrane vesicles, and the sus-
ceptibility of the N- and C-termini of his-FxsA to protease
digestion was then ascertained. The N-terminus of his-FxsA
is not accessible to proteinase K in intact spheroplasts but is
rapidly degraded in inverted membrane vesicles (Fig. 4A).
Thus, in agreement with computer predictions of FxsA
membrane topology, the N-terminus of his-FxsA is cyto-
plasmic. An antibody raised against the C-terminal 37
residues of FxsAwas used to determine the cellular location
of the C-terminus of his-FxsA. Like the N-terminus, the C-
terminus of his-FxsA is resistant to protease in spheroplasts
but is protease-sensitive in inverted membrane vesicles (Fig.
4B). Thus, the C-terminus of his-FxsA is also cytoplasmic,
an experimental result that disagrees with most computer
predictions of FxsA membrane topology.
Direct visualization of spheroplast or inverted membrane
vesicle preparations by microscopy showed few if any intact
cells remained. In spheroplasts, the outer membrane protein
OmpA was completely degraded by proteinase K whereas
the cytoplasmic thioredoxin was resistant (Fig. 4C), indi-
cating that spheroplast formation had preserved the integrity
of the cytoplasmic membrane. We had shown previously
that FxsA is an integral membrane protein (Wang et al.,
1999b); as both the N- and C-termini of his-FxsA are
cytoplasmic, there must be an even number of transmem-
brane domains. Because no fragments of FxsA wereTable 1
Growth of T7 on strains containing N-terminal fragments of FxsA
Plasmid Number of N-terminal Relative plating efficiency
residues in truncated FxsA
IJ511/FVlac
IJ511
30 jC 37 jC
pHisFxsA 158 (wild type) 0.37 0.26
pHisFxsA121 121 0.22 0.21
pHisFxsA115 115 0.4 0.66
pHisFxsA111 111 0.2 0.28
pHisFxsA107 107 0.04a 0.27a
pHisFxsA102 102 <107 <107
pTrchisA b <107 <107
pWF185 158 (wild-type)c 0.32 0.4
pWSK129 b <107 <107
a Pinpoint plaques.
b Vector plasmid.
c Wild-type FxsA without his-tag.detected after proteinase K treatment, we can further con-
clude that the periplasmic segments must be short. The
central periplasmic domain of the E S holin, a known
transmembrane protein, is also resistant to proteinase K
after spheroplast formation (Bla¨si et al., 1999).
FxsA contains four transmembrane segments
To determine both the number and the locations of
transmembrane segments in FxsA, a series of fxsA-phoA
gene fusions were constructed and assayed for phosphatase
activity. Because alkaline phosphatase is only enzymatically
active in the oxidizing environment of the periplasm and is
inactive when in the reducing environment of the cytoplasm
(Boyd et al., 1987a), phosphatase activities of fusion pro-
teins correlate with the cellular location of the domain to
which phosphatase is fused. All the fusion proteins migrated
on SDS-PAGE gels at their expected sizes (Fig. 5A), and
only the K53 fusion protein showed obvious degradation
products. Fusion proteins in which the phosphatase moiety
is localized to the cytoplasm are frequently unstable (San
Millan et al., 1989), and we therefore calculated relative
specific activities of phosphatase for the fusion proteins
based on their rate of synthesis as determined by pulse-
labeling with [35S]methionine. Specific activities of phos-
phatase are likely to reflect more closely the amount of
fusion protein that is potentially available for export.
Fig. 5. Membrane topology of E. coli FxsA. A. Immunoprecipitated pulse-labeled 35S-FxsA-PhoA fusion proteins after electrophoresis on an SDS-
polyacrylamide gel. B. Membrane topology of FxsA. The sites of fusion between fxsA and phoA are designated by the last FxsA amino acid. Phosphatase
assays were conducted in E. coli CC118 containing a fxsA-phoA plasmid. All plasmids are derivatives of pSWFII. Relative specific activities were determined
by dividing phosphatase activity of a fusion protein by its rate of synthesis as shown in A. The rate of synthesis of the T32 fusion was arbitrarily set at unity,
others were normalized to that value. C. Predicted amino acid sequence of FxsA.
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P88, and L95 all exhibit high levels of enzyme activity,
whereas fusions to residues S40, S45, V47, K53, P68, S77,
and P122 show much lower activity (Fig. 5B). These data
lead to a topological model where FxsA possesses four
transmembrane segments. Only two amino acids are pre-
dicted to lie between the first and second, and between the
third and fourth, transmembrane segments of FxsA. Al-
though these amino acids are predicted to be periplasmic,
they are unlikely to be cleaved readily by proteinase K. This
idea is consistent with the protease sensitivity experiment
shown in Fig. 4. Fusions to residues T32 and P102 exhibit
intermediate values of enzyme activity; in the proposed
structure of FxsA, these residues fall near the center of a
transmembrane segment, oriented from the periplasm to-
ward the cytoplasm. The C-terminal residues of the FxsAportion of these fusion proteins may be unstably inserted
into the membrane. Similarly, the higher activity of S40,
S45, and V47, relative to the K53 and P68 fusion proteins
may reflect the need for the positively charged R48 and K53
to anchor the PhoA portion of the fusion protein in the
cytoplasm (Boyd et al., 1987b; San Millan et al., 1989).
Membrane domains of FxsA are essential for alleviating F
exclusion
The membrane topology of FxsA that we have deter-
mined (Fig. 5B) predicts that the fourth transmembrane
domain spans from leucine 95 to histidine 115 and that the
hydrophilic C-terminal 43 amino acids are cytoplasmic. To
investigate the importance of the C-terminus and the mem-
brane domains of FxsA in protecting T7 from F exclusion,
Fig. 6. FxsA interacts with PifA. Cell extracts containing FxsA, which had
been solubilized with buffer containing 2% Triton X-100, were incubated
with Ni-NTA beads containing bound His-PifA or, as a control, phage SP6
His-RNA polymerase. After extensive washing, proteins were eluted from
the resin and subjected to SDS-PAGE. Following electrotransfer to a PVDF
membrane FxsA was visualized using anti-FxsA antibodies.
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terminus were created and their abilities to suppress F
exclusion were then examined. His-FxsA truncations syn-
thesizing only the N-terminal 121, 115, or 111 amino acids
allow T7 to plate at essentially normal efficiency in cells
containing F (Table 1). Thus, the cytoplasmic C-terminal tail
of wild-type FxsA is not important in alleviating F exclusion.
An even shorter form of FxsA, containing only 107 residues,
also permits T7 to plate efficiently on cells containing F at 37
jC. However, at 30 jC, the plating efficiency decreased
about 7-fold. T7 plaques on strains containing FxsA107 are
very small, indicating that the shorter protein has lost much
of its ability to suppress F exclusion. FxsA107 is missing
about one-half of the fourth transmembrane domain (Fig.
5B), and this seems the most likely explanation for the partial
loss of function. The deletion of an additional five amino
acids (FxsA102) causes the complete loss of T7 plaques in F
cells. This inactive mutant protein lacks about two-thirds of
the fourth transmembrane segment, which is consistent with
the idea that this domain is important in exclusion. The
stability of each truncated His-FxsA was examined by
immunoblotting using anti-his-tag antibody. No degradation
of FxsA102, FxsA107, or FxsA111 was detected and the
mutant proteins were all present in comparable amounts
(data not shown), indicating that the loss of function of
FxsA102 and FxsA107 is not due to their inability to
accumulate in the membrane.
PifA and FxsA interact
Overexpression of fxsA allows T7 to productively infect
cells containing PifA (Wang et al., 1999a, 1999b). Inhibition
of FxsA activity by PifA in a T7-infected cell is not thecause of the abortive infection because fxsA null mutants
still allow F exclusion. An alternative idea is that increased
levels of FxsA protect the cell from the combination of PifA
and either of T7 gp1.2 or gp10. As an initial test of this idea,
we asked whether PifA has an affinity for FxsA. His-PifA
was immobilized on Ni-NTA agarose beads and incubated
with an extract of cells containing FxsA. After washing the
resin, bound proteins were eluted and subjected to immu-
noblotting using anti-FxsA antibodies. FxsA was detected
from a resin containing PifA, but not from the unrelated
protein SP6 RNA polymerase (Fig. 6). Thus, F PifA and E.
coli FxsA are interacting proteins.Discussion
The description of T7 as a female-specific phage is
usually attributed to Ma¨kela¨ et al. (1964), although phages
that fail to grow on F+ or Hfr strains of E. coli had been
isolated previously (Dettori et al., 1961; Hakura and Hirota,
1961; Hakura et al., 1964; Watanabe and Okada, 1964;
Zinder, 1961). However, it was only later that the related-
ness between some of these phages and T7 was appreciated.
T7 is now the prototype phage of the T7 family, which
contains more than 60 representative coliphages plus addi-
tional phages that grow on other Gram-negative genera.
Most of the coliphages, the salmonellaphage SP6, and the
yersiniophage A1122 (also known as phage H) are all
excluded in cells containing the F plasmid (Duckworth
et al., 1981; Garcia et al., 2003; Molineux, 1991; Scholl et
al., 2004; Studier, 1979; Zinder, 1961). However, the Y.
enterocolitica phage YeO3-12 and its descendant, the coli-
phage T3, grow normally in F cells (Pajunen et al., 2001,
2002). The important difference between these last two
phages and the remainder of the T7 group is gene 1.2; T3
gene 1.2 prevents exclusion whereas expression of T7 gene
1.2 actually causes exclusion (Condreay and Molineux,
1989; Garcia and Molineux, 1995; Molineux, 1991; Moli-
neux and Spence, 1984; Schmitt and Molineux, 1991). An
activity of T3 gene 1.2 prevents the newly synthesized gp10
capsid protein of the phage from interacting with the F
protein PifA. The major capsid protein of all T7 family
members that have been tested is capable of triggering
exclusion in cells containing the F protein PifA.
The pif operon of the F plasmid codes for the autor-
egulatory repressor PifC and the T7 exclusion protein PifA
(Cram et al., 1984a, 1984b; Rotman et al., 1983; Miller and
Malamy, 1983, 1984). PifC also represses RP4 conjugal
transfer (Miller et al., 1985). Close homologues of PifC
have only been found on the large virulence plasmid
pLVPK of Klebsiella pneumoniae CG43 and on the Sal-
monella typhimurium conjugal plasmid R64, both of which
also harbor a PifA homologue. R64 (and also R56) has
been reported to inhibit the growth of T7 (Hughes and
Meynell, 1973). In addition, close homologues of PifA
have been found on a transmissible plasmid and in a
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However, the only biological function yet known is that of
T7 exclusion by F PifA, and no biochemical property of
PifA has been determined.
Although we could not identify any transmembrane
domains, it is clear that PifA is a membrane-associated
protein, and exclusion of T7 is therefore likely to involve
membrane functions. In contrast, both T7 gp1.2 and gp10
are soluble proteins and must be recruited to the cytoplasmic
membrane to elicit the physiological defects that are asso-
ciated with exclusion. It is not yet clear whether PifA is
directly involved in this recruitment, although complexes
between PifA and both T7 gp1.2 and gp10 have been
detected (X.C and I.J.M., unpublished observations).
The combination of PifA and either T7 gp1.2 or gp10 is
lethal to E. coli and must therefore inhibit an essential cell
function (Schmitt and Molineux, 1991). E. coli FxsA plays a
protective role and can prevent exclusion when present at
higher than normal concentration (Wang et al., 1999a,
1999b). However, FxsA is a nonessential protein and is not
the target of PifA and T7 gp1.2 (or gp10) because fxsA null
mutants still allow F to exclude T7. FxsA is a membrane
protein, and we have shown here that it contains four
transmembrane segments with cytoplasmic N- and C-termini.
As the second residue of FxsA is arginine, the initiating
methionine should be retained, the cytoplasmic N-terminal
segment of FxsA therefore contains only two amino acids
with Arg2 serving as the first transmembrane segment
anchor. In accordance with the ‘‘positive inside rule’’
(von Heijne, 1989), the second membrane segment may
be anchored in the cytoplasm by Arg48 and perhaps
Lys53. In higher copy number vectors, where the rate of
plasmid protein synthesis was increased 4.5-fold over the
experiments shown in Fig. 5, a fusion of Val47 to PhoA
gave blue colonies on XP plates and had substantial
phosphatase activity (data not shown). The increased rate
of protein synthesis is presumably sufficient to allow
significant export of the PhoA portion of the fusion
protein. Similar observations have been reported for
MalF-PhoA (Boyd et al., 1987b) and LacY-PhoA fusions
(Calamia and Manoil, 1990). The exact positions of the
third and fourth transmembrane segments are less well
defined, although it is clear that FxsA has four transmem-
brane domains. The two periplasmic domains are both
predicted to contain just two residues, which is consistent
with their being resistant to proteinase K in spheroplasts.
Arginines at residues 117 and 120 must help maintain the
C-terminal domain in the cytoplasm, but whether Lys111 is
within the membrane, as indicated in Fig. 5B, or whether it
defines the end of the transmembrane segment is unclear.
The cytoplasmic C-terminal tail of FxsA thus contains
between 43 and 47 amino acids. Remarkably, the last 22
residues contain 16 charged amino acids, more than half
that found in the entire protein.
The C-terminal tail is, however, not important in allevi-
ating F exclusion of T7. Removal of the last 47 amino acidsof FxsA has no effect on the ability of the protein to allow
T7 to grow in the presence of F (FxsA111, Table 1).
Removing 51 amino acids (FxsA107) still provides a protein
with some activity, even though the fourth transmembrane
segment of the mutant protein must be incomplete. How-
ever, removing 56 amino acids (FxsA102) yields a protein
with no detectable ability to prevent F exclusion of T7.
These results indicate that the fourth membrane domain of
FxsA is required for its activity in preventing F exclusion of
T7. The FxsA102-PhoA fusion had an intermediate level of
phosphatase activity (Fig. 5), suggesting that only a fraction
of the PhoA portion was periplasmic. It is possible that the
failure of FxsA102 to alleviate F exclusion of T7 is due to
there being insufficient FxsA with its C-terminus in the
membrane. Even if this were the case, the fourth transmem-
brane segment of FxsA must still be considered essential for
activity, and we suggest that this segment constitutes part of
a binding site for PifA. As PifA is membrane-associated
even when FxsA is not overexpressed, it seems likely that
the cytoplasmic membrane is the site where T7 exclusion by
F is first manifest.
fxsA is monocistronic, the gene is transcribed from its
own promoter in the opposite orientation to both the
upstream aspA (aspartase) gene and the downstream yjeH,
a gene of unknown function (Wang et al., 1999a). The
cellular function of FxsA is unknown; although moderate
overexpression of fxsA is tolerated well by the cell, gross
overexpression has a deleterious effect on growth rate
(Wang et al., 1999a, 1999b). In contrast, fxsA null mutants
grow normally; isogenic fxsA+ and fxsA null mutants are
maintained during competitive growth in both rich and
minimal glucose media at 30 and 37 jC (X.C. and I.J.M.,
unpublished data). Although normal fxsA expression levels
are insufficient to prevent F exclusion of T7, a 25-fold
increase, caused by the promoter-up chromosomal mutation
fxsAp109, allows T7 to grow normally in F cells.
T7 exclusion by F is accompanied by a premature in-
hibition of macromolecular synthesis and a membrane
defect that allows intracellular nucleotides and other small
molecules to leak from the abortively infected cell. Al-
though leakiness of the membrane has been proposed to be
the cause of exclusion, no correlation between leakiness
and inhibition of phage growth has been observed. Two
chromosomal loci that were found serendipitously to
alleviate F exclusion of T7 are rpsL, defined here by
certain mutations causing a StrR phenotype, and galU
(Chakrabarti and Gorini, 1975; Remes and Elseviers,
1980). Both mutant strains continue to leak ATP from
the cell into the extracellular fluid during T7 growth
(Remes and Elseviers, 1980; Schmitt et al., 1991). Fur-
thermore, T7 mutants that grow in the presence of F still
leak ATP, albeit at a reduced level (Molineux et al., 1989;
Schmitt et al., 1991). Similarly, overexpression of fxsA not
only allows wild-type T7 to grow in the presence of F but
also allows a reduced level of leakiness (Wang et al.,
1999b).
Table 2




galK thi rpsE rpoB
argE(Am) recA1
Manoil and Beckwith, 1985
CC202 CC118/F42 lacI3 zzf-2::TnphoA Manoil and Beckwith, 1985
IJ511 DlacX74 galK2 galT22
supE44 hsdS3
Condreay and Molineux, 1989
IJ1198 lacX74 galK150(Am)cysI53(Am)
trp(Am) supF
Wang et al., 1999a
IJ1199 IJ1198 fxsAp109 Wang et al., 1999a
IJ1200 IJ1198D (srlR-recA)306::Tn10 Wang et al., 1999a
Top10 mcrAD (mrr-hsdRMS-mcrBC)
[ø80dlacZD M15]
DlacX74 deoR recA1 araD139D
(ara-leu)7697 galU galK rpsL
endA1 nupG
Invitrogen
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a plausible mechanism for T7 exclusion by F and its
alleviation by high concentrations of FxsA. We suggest that
in wild-type cells containing F, the membrane-associated
protein PifA interacts primarily with an essential E. coli
membrane protein and only a small fraction with FxsA.
Despite considerable effort, the identity of this essential
membrane protein has remained elusive, but only its inter-
action with PifA is important for exclusion of T7. Although
T7 gp1.2 and gp10 are both soluble proteins, some fraction
must be recruited to the membrane by either PifA or the E.
coli membrane protein whose activity is essential. The
primary consequence of the combination of T7 and F
proteins binding to the essential E. coli protein is that its
activity is inhibited, a secondary event perhaps alters the
conformation of the protein. Inhibition of activity ultimately
leads to the loss of biosynthetic capacity and active transport
in the cell; the hypothesized conformational change in the
membrane protein allows intracellular ATP and other small
molecules to leak out of the cell. Although they may be
related events, there is no obligate coupling between the
conformational change in the membrane protein and the
inhibition of its activity. FxsA can suppress F exclusion
when present at higher than normal intracellular concen-
trations. In this situation, FxsA simply competes effectively
for PifA and thereby sequesters it at sites where it cannot
interfere with the activity of the essential E. coli membrane
protein. Consequently, after T7 infection, when gp1.2 and
gp10 are synthesized, the phage proteins may interact
normally with the essential membrane protein as if they
were present in an Fcell, or they may interact with FxsA-
bound PifA. In the latter case, the resulting complex must
still be unable to inhibit the activity of the essential
membrane protein. This idea suggests that FxsA has no
mechanistic role in the process of phage exclusion, in-
creased levels of FxsA simply compete effectively for PifA
and prevent it from binding an essential membrane protein.
In pure culture, cells harboring F pifA mutant plasmids
have not been shown to exhibit growth defects, relative to
those harboring F+. Under laboratory conditions, pifA there-
fore offers no clear advantage to either F or the host
bacterium. However, in a natural environment, pifA may be
considered to endow a population of cells containing F a
level of resistance to the majority of T7-like coliphages
which, like T7 itself, are subject to F exclusion. Resistance
may be sufficient for maintaining pifA in F and other
conjugal plasmids, and also in chromosomal pathogenicity
islands that may themselves be plasmid-derived. It is unlike-
ly that this is the primary or sole function of pifA; resistance
of a population to T7-like phages would do little more than
select for the proliferation of phages like T3, which are
insensitive to exclusion. However, our limited knowledge on
the population structure of the T7 family of phages suggests
that the majority are sensitive to F exclusion. In turn, this line
of thought suggests that pifA has another function in the
biology of F and related plasmids.PifA fractionates with the cytoplasmic membrane, and it
is conceivable that the protein thus acts as a sensor for
certain environmental changes experienced by the cell.
Related, albeit more specific, ideas have been raised for
the function of the E rex system, which, in addition to
causing infections by T-even phages that lack the rII genes
to be aborted, has been proposed to interact with the
stationary phase response of the cell and to inhibit the ClpP
family of proteases (Engelberg-Kulka et al., 1998; Slavcev
and Hayes, 2003). If PifA acts as a biological sensory
system for F, why should the expression of T7 gene 1.2
or gene 10 then abrogate phage development and lead to
death of the infected cell? We can speculate that the T7
proteins also have a sensory function that may be distinct
from their known activities in inhibiting E. coli dGTPase
and in head assembly, perhaps an activity that involves the
same cellular proteins or structures that are utilized by PifA.
The abortive infection of T7 in F cells may then be a result
of both the plasmid and phage genes simultaneously inter-
acting with—and inhibiting as a consequence—the same
cellular activities. Transcription in T7-infected cells is
terminated earlier than usual when synthesis of both gp1.2
and gp10 is prevented (Beck and Molineux, 1991), possibly
suggesting that the two proteins cooperate in sensing the
triphosphate pools or overall energy levels in the infected
cell. In this hypothetical scenario, PifA would also monitor
the same functions that help maintain energy levels in
uninfected E. coli cells.Methods of procedure
Bacterial strains and plasmids
The E. coli strains and plasmids used in this study are
listed in Tables 2 and 3. Unless indicated otherwise,
bacterial cultures were grown at 37 jC in rich medium
(per liter: 10 g Bactotryptone, 5 g yeast extract, 5 g NaCl)
Table 3
Plasmids
Name Replicon, relevant genes Source
pAK25 pUC9; T7 gene 1.2 under
Plac control





pGX25 pTrchisB; pifAD (1–462)
[C-terminal 254 codons]
This work
pGX26 pTrchisB; pifAD (1–180)
[C-terminal 536 codons]
This work
pGX31 pTrchisA; pifA-K59A under
Ptrc control
This work
pGST1.2 pGEX-3X, gst-T7 1.2 This work
pGSTFxsA-C pGEX-3X; gst fused to fxsAD
(1–121) [C-terminal 37 codons]
This work
pHisFxsA pTrchisB; his-fxsA under
Ptrc control
This work
pHisFxsA102 pTrchisA; fxsAD (103–158) This work
pHisFxsA107 pTrchisA; fxsAD (108–158) This work
pHisFxsA111 pTrchisA; fxsAD (112–158) This work
pHisFxsA115 pTrchisA; fxsAD (116–158) This work
pHisFxsA121 pTrchisA; fxsAD (122–158) This work
pQ pACYC184::lacIq TcR Lab collection
pSWFII pBR322, signal sequence-less
and promoter-less phoA
Ehrmann et al., 1990
pTrchisA,B,C pBR322, N-terminal his-tag
vector, under Ptrc control
Invitrogen
pWSK10A pWSK29, T7 10A under
Plac control
This work
pWF184 pWSK29, fxsA+, fxsAp109 and
Plac control
Wang et al., 1999a
pWF185 pWSK29, fxsA+, fxsAp+, and
Plac control
Wang et al., 1999a
pWSK29 pSC101 replicon, cloning vector Wang and Kushner,
1991
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plasmids. All fxsA-phoA fusion plasmids were constructed
by ligating PCR products of various fxsA 5V-proximal
coding sequences using oligonucleotides containing a PstI
or SmaI site. After digestion, the PCR product was ligated
into the polylinker of pSWFII, a plasmid containing a
promoter-less, signal sequence-less alkaline phosphatase
gene (Ehrmann et al., 1990). In these fusions, transcription
of the fusion is from the fxsAp+ promoter. The fxsA deletions
were made by PCR using pWF185 DNA as template. A
UAA stop codon was placed immediately after the last sense
codon of the truncated fxsA. The PCR product was then
cloned into the expression vector pTrchisA. The sequences
of all oligonucleotides used in making fxsA mutants and
fxsA-phoA fusions are available upon request. Other plas-
mids were made using standard cloning procedures.
Antibodies
Polyclonal antisera were produced by following the
procedure described in ‘‘Current Protocols in Molecular
Biology’’ (Struhl et al., 1992). Briefly, purified protein in
PBS (pH 7.4) was mixed and emulsified with an equal
volume of complete Freunds adjuvant (CFA, Sigma). A dosecorresponding to 0.5 mg protein was injected subcutaneous-
ly into a female New Zealand rabbit. Booster immunizations
using incomplete Freunds adjuvant were administered three
times every 3 weeks after the primary injection. The follow-
ing proteins were used as antigens to generate corresponding
antisera: gp10A, GST-1.2, His-PifA, and GST-FxsA-C (last
37 amino acids of FxsA fused to the C-terminus of GST).
Gp10A was purified following the method of Cerritelli and
Studier (1996), other proteins by commercial affinity resins.
Antisera were collected 2 weeks after each boost and were
stored in aliquots as crude serum at 20 jC. Dr. C. Earhart,
University of Texas, kindly provided antibodies to E. coli
OmpA and thioredoxin. Anti-PhoA antibodies were pur-
chased from Chemicon International.
Cellular localization of proteins
PifA
A 200-ml culture of IJ511/FVlac at A600 = 0.7 was
centrifuged and cells were resuspended in 5 ml PBS (pH
7.4) and broken by passage through a French pressure cell.
After clarification of the lysate, the membrane fraction was
collected by centrifugation at 100000  g for 2 h at 4 jC
and resuspended in 5 ml PBS (pH 7.4). The supernatant
was saved as the soluble fraction. For determining Sarkosyl
solubility, the membrane suspension was incubated on
ice with 0.5% Sarkosyl for 10 min and centrifuged at
100000  g for 2 h at 4 jC. After dissolving the pellet
in 5 ml PBS, both the pellet suspension and the supernatant
were dialyzed against PBS (pH 7.4). In some experiments,
the original crude membrane preparation was resuspended
in PBS containing 1 M NaCl. After shaking at 4 jC for
20 min, the membrane was collected as described above.
Samples from each fraction were subjected to SDS-PAGE
and examined for the presence of PifA by immunoblotting
using anti-PifA antibody.
T7 gp1.2 and gp10A
For gp1.2, a 100-ml culture of IJ1199(Q)(pAK25) at
A600 = 0.4 was induced with 0.1 mM IPTG until A600 = 0.7.
For gp10A, IJ1199(Q)(pWSK10A) was grown to A600 = 0.7
at 37 jC without induction. Harvested cells were resus-
pended in 5 ml of 50 mM Tris–HCl pH 8.0 and were
disrupted using a French press. After removal of cell debris,
cell extracts were centrifuged at 100000  g at 4 jC for 2 h.
The total membrane fraction was suspended in 50 mM
Tris–HCl pH 8.0. The presence of gp10A and gp1.2 in the
cytoplasmic and membrane fractions was determined by
SDS-PAGE and immunoblotting using anti-gp10A or anti-
gp1.2 antibody.
Separation of inner and outer membranes
Membranes were prepared from strain IJ511/FVlac using
the method of Osborn et al. (1972). A 200-ml culture was
grown to a cell density of 5 108 per ml at 37 jC. Cells were
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ml of an ice-cold solution of 0.75 M sucrose, 10 mM Tris–
HCl (pH 7.8), and incubated with 100 Ag/ml lysozyme for 2
min. Twenty milliliters of ice-cold 1.5 mM EDTA (pH 7.5)
was then added slowly with gentle mixing over a period of 10
min. Spheroplasts were broken by one passage of the sus-
pension through a French pressure cell at 16000 psi. After
removal of cell debris by centrifugation at 10000 rpm for 10
min, crude membranes were collected by centrifugation at
150000 g for 2 h at 4 jC and were then gently resuspended
in 10 ml of 0.25 M sucrose, 3.3 mM Tris–HCl, 1 mM EDTA
(pH 7.5). After centrifugation at 150000  g for 2 h at 4 jC,
the membrane fraction was resuspended in 1 ml 25% (w/w)
sucrose, 5 mMEDTA (pH 7.5), and was then loaded on top of
a step sucrose gradient (0.5 ml of 55%, 0.7 ml each of 50%,
45%, 40% 35%, and 30% sucrose (all w/w)). Inner and outer
membranes were separated by centrifugation in a SW55 rotor
at 120000  g for 14 h at 4 jC; 250-Al fractions were
collected from the tube bottom. Protein concentration was
determined using the Bradford reagent. For assaying the
activity of NADH oxidase, 5 Al of each gradient fraction
was incubated for 10 min at 37 jC with 1 ml of 50 mM Tris–
HCl (pH 7.5), 0.12 mM NADH, 0.2 mM dithiothreitol.
NADH oxidase activity was measured as the decrease in
absorbance at 340 nm. Relative amounts of PifA and OmpA
in fractions were determined by immunoblotting using anti-
OmpA and anti-PifA antibodies after electrophoresis through
a 12% SDS-PAGE gel followed by electrophoretic transfer of
the proteins to a PVDF membrane.
SDS-PAGE and immunoblotting
Proteins were resolved by SDS-PAGE using 12% (for
gp10A, PifA, and FxsA) or 15% (for gp1.2) acrylamide.
Proteins were then electrophoretically transferred to a
PVDF membrane. After blocking with 5% nonfat milk in
TBS (20 mM Tris–HCl, 500 mM NaCl, pH 7.5) for 1 h,
the membrane was incubated with primary antibody in
TTBS (20 mM Tris–HCl, 500 mM NaCl, 0.05% Tween
20, pH 7.5) for 1 h and then incubated with TTBS
containing a secondary antibody conjugated to alkaline
phosphatase for 1 h. Primary antibodies were used at the
dilution of 1:10000 for anti-gp10A antibody, 1: 5000 for
anti-PifA antibody, 1: 3000 for anti-gp1.2 and FxsA anti-
bodies. Secondary antibodies were diluted in TTBS at 1:
5000 for goat anti-rabbit antibody (Bio Rad) and 1:3000
for goat anti-mouse antibody (Kirkegard and Perry Lab,




One hundred milliliters of IJ1200(pWF185) or IJ11-
98(pHisFxsA) was grown at 37 jC to A600 = 0.7 and
harvested by centrifugation. Cells were suspended in 10 mlof ice-cold 0.5 M sucrose, 100 mM Tris–HCl, pH 8.0, 5 mM
EDTA. After addition of lysozyme to 80 Ag/ml, an equal
volume of ice-cold H2O was added and the mixture was
incubated on ice for 10 min. Spheroplast formation was
monitored by microscopy. After adding MgSO4 to 20 mM,
spheroplasts were collected by brief centrifugation and were
then resuspended in 10 ml of ice-cold 0.25 mM sucrose,
50 mM Tris–HCl (pH 8.0), 10 mM MgSO4 (Cao and
Dalbey, 1994).
Inverted membrane vesicles (IMV)
One hundred milliliters of IJ1200(pWF185) or IJ-
1200(pHisFxsA) cells were grown and harvested as de-
scribed above for spheroplasts. Cells were suspended in 10
ml of 50 mM Tris–HCl, pH 8.0, 0.1 mM NaCl, 20 mM
EDTA and were disrupted by a single passage through a
French pressure cell at 16000 psi. Unbroken cells and debris
were removed by centrifugation at 5000  g for 10 min at 4
jC. This procedure results in the conversion of at least 95%
of cells into inverted membrane vesicles (Bla¨si et al., 1999;
Gru¨ndling et al., 2000).
Proteinase K treatment
One milliliter of a spheroplast or IMV suspension was
treated with 1 mg/ml proteinase K at 37 jC for various
times; digestion was stopped by the addition of 2 mM
PMSF. A separate sample was treated with 2% Triton X-
100 before proteinase K treatment. Spheroplasts were col-
lected by centrifugation at 10000 rpm for 1 min, IMV by
centrifugation at 100000  g for 2 h. Pellets were dissolved
in 2 SDS-loading buffer and boiled for 5 min before SDS-
PAGE analysis. The presence of FxsA was determined by
immunoblotting using antibody against either the C-termi-
nus of FxsA or (for His-FxsA) anti-his-tag antibody.
Pulse-labeling and detection of FxsA-PhoA fusion proteins
E. coli CC118 cells containing a fxsA-phoA fusion
plasmid were grown in M9 minimum medium supple-
mented with 0.2% glucose, 100 Ag/ml arginine and leucine,
20 Ag/ml thiamine, 1 mM MgSO4, and 100 Ag/ml ampicillin
at 37 jC to A600 = 0.3. One milliliter of culture was labeled
with 100 ACi [35S]methionine (1175 Ci/mmol; NEN) for
1 min. Immunoprecipitation followed the procedure of Ito
(1981). After centrifugation, the cell pellet was dissolved in
20 Al of 1% SDS, 50 mM Tris–HCl (pH8.0), 1 mM EDTA,
and boiled for 2 min. Ice-cold buffer (2% Triton X-100, 50
mM Tris–HCl, pH 8.0, 0.15 M NaCl, 0.1 mM EDTA, 660
Al) was then added. A nonspecific precipitate was removed
by centrifugation, 2 Al of anti-PhoA antibody was added,
and the mixture was incubated at 4 jC for 1 h. Forty
microliters of 33% protein A-agarose beads was then added
and the mixture was again incubated at 4 jC for 1 h. Beads
were collected, washed twice with buffer containing Triton
X-100, once with 10 mM Tris–HCl, pH 8.0, and then boiled
for 2 min in a reducing SDS-PAGE loading buffer. After
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phosphorimagery and bands were quantitated using Image-
Quant software.
Alkaline phosphatase assays
Alkaline phosphatase activities were measured by a
modified procedure of Brickman and Beckwith (1975).
Log-phase CC118 cells containing the test plasmid (1.5 ml
of culture) were resuspended in 1 ml 1 M Tris–HCl pH 8.0
and the A600 was measured. Cells were permeabilized by the
addition of 10 Al CHCl3, 10 Al 10% SDS, and 50 Al of 80 mg/
ml p-nitrophenyl phosphate (Sigma 104 phosphatase sub-
strate). The mixture was incubated at room temperature for
10 min and the reaction terminated by the addition of 100 Al
1 M K2HPO4. After removal of cell debris by centrifugation,
the A420 of the supernatant was measured. Activity is
calculated as units = 1000  A420/(t  A600), where t = time
of incubation. Background values were obtained from a
strain containing the vector plasmid pSWFII and were
subtracted from the activity of each fxsA-phoA fusion.
TnphoA insertions
TnphoA insertions into various pifA plasmids were se-
lected using the strain CC202 as described (Manoil and
Beckwith, 1985). Plasmid DNA was isolated and trans-
formed into the phoA strain CC118. Transformants that
were blue on plates containing 5-bromo-4-chloro-3-indolyl
phosphate (i.e., are PhoA+) were purified, and plasmid DNA
was isolated. The site of transposon insertion into the pifA
plasmid was determined by DNA sequencing.
Affinity chromatography of FxsA
His-PifA (0.5 mg) and His-tagged SP6 RNA polymerase
(0.5 mg) in 0.5 ml were each incubated with 0.1 ml Ni-NTA
agarose beads in a buffer (50 mM Na2HPO4 pH8.0, 25 mM
NaCl) containing 10 mM imidazole for 2 h at 4 jC. The
resin was then washed with the same buffer to remove
unbound protein. Cells from a 5-ml culture of IJ1199
(overexpressing fxsA) were harvested, lysed in the presence
of 2% Triton X-100 to ensure that membrane proteins were
solubilized, and incubated with 50 Al of PifA resin. After
extensive washing with buffer containing 20 mM imidazole,
proteins were eluted using buffer containing 250 mM im-
idazole. The eluate was subjected to SDS-PAGE, electro-
transferred to a PVDF membrane, and probed with anti-
FxsA antibodies.Acknowledgments
This work was supported by grants GM32095 from the
National Institutes of Health and MCB 9506954 from the
National Science Foundation.ReferencesBeauchamp, B.B., Richardson, C.C., 1988. A unique deoxyguanosinetri-
phosphatase is responsible for the OptA1 phenotype of Escherichia
coli. Proc. Natl. Acad. Sci. U.S.A. 85, 2563–2567.
Beck, P.J., Molineux, I.J., 1991. Defective transcription of the right end
of bacteriophage T7 DNA during an abortive infection of F plasmid-
containing Escherichia coli. J. Bacteriol. 173, 947–954.
Bla¨si, U., Fraisl, P., Chang, C.-Y., Zhang, N., Young, R., 1999. The C-
terminal sequence of the E holin constitutes a cytoplasmic regulatory
domain. J. Bacteriol. 181, 2922–2929.
Boyd, D., Guan, C.-D., Willard, S., Wright, W., Beckwith, J., 1987a. The
enzymatic activity of alkaline phosphatase precursor depends on its
cellular location. In: Torriani-Gorini, A.M., Rothman, F.G., Silver, S.,
Wright, A., Yagil, E. (Eds.), Phosphate Metabolism and Cellular Re-
gulation in Microorganisms. American Society for Microbiology. Wash-
ington, DC, pp. 89–93.
Boyd, D., Manoil, C., Beckwith, J., 1987b. Determinants of membrane
protein topology. Proc. Natl. Acad. Sci. U.S.A. 84, 8525–8529.
Brickman, E., Beckwith, J., 1975. Analysis of the regulation of E. coli
alkaline phosphatase synthesis using deletion and ø80 transducing
phages. J. Mol. Biol. 96, 307–316.
Britton, J.R., Haselkorn, R., 1975. Macromolecular synthesis in T7 infected
FV cells. Virology 67, 264–275.
Calamia, J., Manoil, C., 1990. Lac permease of E. coli: topology and
sequence elements promoting membrane insertion. Proc. Natl. Acad.
Sci. U.S.A. 87, 4937–4941.
Cao, G., Dalbey, R., 1994. Translation of N-terminal tails across the plasma
membrane. EMBO J. 13, 4662–4669.
Cerritelli, M.E., Studier, F.W., 1996. Assembly of T7 capsids from inde-
pendently expressed and purified head protein and scaffolding protein.
J. Mol. Biol. 258, 286–298.
Chakrabarti, S.L., Gorini, L., 1975. Growth of bacteriophages MS2 and T7
on streptomycin-resistant mutants of Escherichia coli. J. Bacteriol. 121,
670–674.
Coffey, A., Ross, R.P., 2002. Bacteriophage-resistance systems in dairy
starter strains: molecular analysis to application. Antonie van Leeuwen-
hoek 82, 303–321.
Condit, R.C., Steitz, J.A., 1975. F factor-mediated inhibition of bacterio-
phage T7 growth: analysis of T7 RNA and protein synthesis in vivo
and in vitro using male and female Escherichia coli. J. Mol. Biol. 98,
31–43.
Condreay, J.P., Molineux, I.J., 1989. Synthesis of the capsid protein inhibits
development of bacteriophage T3 mutants that abortively infect F plas-
mid containing cells. J. Mol. Biol. 207, 543–554.
Cram, D., Ray, A., Skurray, R., 1984a. Molecular analysis of F plasmid pif
region specifying abortive infection of T7. Mol. Gen. Genet. 197,
137–142.
Cram, H.K., Cram, D., Skurray, R., 1984b. F plasmid pif region: Tn1725
mutagenesis and polypeptide analysis. Gene 32, 251–254.
Dettori, R., Maccacaro, G.A., Piccinin, G.L., 1961. Sex-specific bacte-
riophages of Escherichia coli K-12. Giorn. Microbiol. 9, 141–150.
Duckworth, D.H., Glenn, J., McCorquodale, D.J., 1981. Inhibition of bac-
teriophage replication by extrachromosomal genetic elements. Micro-
biol. Rev. 45, 52–71.
Ehrmann, M., Boyd, D., Beckwith, J., 1990. Genetic analysis of membrane
protein topology by sandwich gene fusion approach. Proc. Natl. Acad.
Sci. U.S.A. 87, 7574–7578.
Engelberg-Kulka, H., Reches, M., Narasimhan, S., Schoulaker-Schwarz,
R., Klemes, Y., Aizenman, E., Glaser, G., 1998. rexB of bacterio-
phage E is an anti-cell death gene. Proc. Natl. Acad. Sci. U.S.A. 95,
15481–15486.
Filip, C., Fletcher, G., Wulff, J.L., Earhart, C.F., 1973. Solubilization of the
cytoplasmic membrane of E. coli by the ionic detergent sodium-lauryl
sarcosinate. J. Bacteriol. 115, 717–722.
Garcı´a, L.R., Molineux, I.J., 1995. Incomplete entry of bacteriophage T7
X. Cheng et al. / Virology 326 (2004) 340–352352DNA into F plasmid-containing E. coli strain. J. Bacteriol. 177,
4077–4083.
Garcia, E., Elliott, J.M., Ramanculov, E., Chain, P.S.G., Chu, M.C., Moli-
neux, I.J., 2003. The genome sequence of Yersinia pestis bacteriophage
øA1122 reveals an intimate history with the coliphage T3 and T7
genomes. J. Bacteriol. 185, 5248–5262.
Gru¨ndling, A., Bla¨si, U., Young, R., 2000. Biochemical and genetic evi-
dence for three transmembrane domains in the class I holin, E S. J. Biol.
Chem. 275, 769–776.
Hakura, A., Hirota, Y., 1961. Sex determining temperate phage H (tau) in
Escherichia coli. Jpn. J. Genet. 36, 379.
Hakura, A., Otsuji, N., Hirota, Y., 1964. A temperate phage specific for
female strains of Escherichia coli K-12. J. Gen. Microbiol. 35, 69–73.
Huber, H.E., Beauchamp, B.B., Richardson, C.C., 1988. E. coli dGTP
triphosphohydrolase is inhibited by gene 1.2 protein of bacteriophage
T7. J. Biol. Chem. 263, 13549–13556.
Hughes, V., Meynell, G.G., 1973. The contribution of plasmid and phage
genes to plasmid-mediated interference with phage growth. Genet. Res.
30, 179–185.
Ito, K., 1981. Protein localization in E. coli: is there a common step in the
secretion of periplasmic and outer-membrane protein? Cell 24, 707–717.
Kennedy, M., Chandler, M., Lane, D., 1988. Mapping and regulation of the
pifC promoter of the F plasmid. Biochim. Biophys. Acta 950, 75–80.
Koonin, E.V., 1993. A superfamily of ATPases with diverse functions
containing either classical or deviant ATP-binding motif. J. Mol. Biol.
229, 1165–1174.
Ma¨kela¨, O., Ma¨kela¨, P.H., Soikkeli, S., 1964. Sex-specificity of the bacte-
riophage T7. Ann. Med. Exp. Biol. Fenn. 42, 188–195.
Manoil, C., Beckwith, J., 1985. TnphoA: a transposon probe for protein
export signals. Proc. Natl. Acad. Sci. U.S.A. 82, 8129–8133.
Miller, J.F., Malamy, M.H., 1983. Identification of the pifC gene and its
role in negative control of F factor gene expression. J. Bacteriol. 156,
338–347.
Miller, J.F., Malamy, M.H., 1984. Regulation of the F-factor pif operon:
pifO, a site required in cis for autoregulation, titrates the pifC product in
trans. J. Bacteriol. 160, 192–198.
Miller, J.F., Lanka, E., Malamy, M.H., 1985. F factor inhibition of conju-
gal transfer of broad-host-range plasmid RP4: requirement for the pro-
tein product of Pif operon regulatory gene pifC. J. Bacteriol. 163,
1067–1073.
Molineux, I.J., 1991. Host–parasite interactions: recent developments in
the genetics of abortive phage infections. New Biol. 3, 230–236.
Molineux, I.J., Spence, J.L., 1984. Virus-plasmid interactions: mutants of
bacteriophage T3 that abortively infect plasmid F-containing (F+) strains
of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 81, 1465–1469.
Molineux, I.J., Schmitt, C.K., Condreay, J.P., 1989. Mutants of bacterio-
phage T7 that escape F restriction. J. Mol. Biol. 207, 563–574.
Morrison, T.G., Malamy, M.H., 1971. T7 translational control mecha-
nisms and their inhibition by F factors. Nature (London), New Biol.
231, 37–41.
Myers, J.A., Beauchamp, B.B., White, J.H., Richardson, C.C., 1987. Pu-
rification and characterization of the gene 1.2 protein of bacteriophage
T7. J. Biol. Chem. 262, 5280–5287.
Nakai, H., Richardson, C.C., 1990. The gene 1.2 protein of bacteriophage
T7 interacts with the Escherichia coli dGTP triphosphohydrolase to
form a GTP-binding protein. J. Biol. Chem. 265, 4411–4419.
Osborn, M.J., Gander, J.E., Parisi, E., Carson, J., 1972. Mechanism of
assembly of outer membrane of Salmonella typhimurium. J. Biol.
Chem. 247, 3962–3972.
Pajunen, M.I., Kiljunen, S.J., So¨derholm, M.E.-L., Skurnik, M., 2001.
Complete genomic sequence of the lytic bacteriophage øYeO3-12 of
Yersinia enterocolitica serotype O:3. J. Bacteriol. 183, 1928–1937.
Pajunen, M.I., Elizondo, M.R., Skurnik, M., Kieleczawa, J., Molineux, I.J.,
2002. Complete nucleotide sequence and likely recombinatorial origin
of bacteriophage T3. J. Mol. Biol. 319, 1115–1132.
Remes, B., Elseviers, D., 1980. Adenosine 5V-triphosphate leakage doesnot cause abortive infection of bacteriophage T7 in male Escherichia
coli. J. Bacteriol. 143, 1054–1056.
Rotman, G.S., Cooney, R., Malamy, M.H., 1983. Cloning of the pif region
of the sex factor and identification of pif protein product. J. Bacteriol.
155, 254–264.
Saito, H., Richardson, C.C., 1981. Genetic analysis of gene 1.2 of bacte-
riophage T7: isolation of a mutant of Escherichia coli unable to support
the growth of T7 gene 1.2 mutants. J. Virol. 37, 343–351.
San Millan, J.L., Boyd, D., Ross, D., William, W., Beckwith, J., 1989. Use
of phoA fusions to study the topology of the E. coli inner membrane
protein leader peptidase. J. Bacteriol. 171, 5536–5541.
Schmitt, C.K., 1989. Incompatibility of T7 gene 1.2 with the F plasmid is
the basis for F-mediated restriction of T7. Ph. D. Dissertation. Univer-
sity of Texas at Austin.
Schmitt, C.K., Molineux, I.J., 1991. Expression of gene 1.2 and gene 10 of
bacteriophage T7 is lethal to F plasmid containing E. coli. J. Bacteriol.
173, 1536–1543.
Schmitt, C.K., Kemp, P., Molineux, I.J., 1991. Genes 1.2 and 10 of bacte-
riophages T3 and T7 determine the permeability lesions observed in
infected cells of E. coli expressing the F plasmid gene pifA. J. Bacteriol.
173, 6507–6514.
Schmitt, M.P., Beck, P.J., Kearney, C.A., Spence, J.L., DiGiovanni, D.,
Condreay, J.P., Molineux, I.J., 1987. Sequence of a conditionally es-
sential region of bacteriophage T3, including the primary origin of
DNA replication. J. Mol. Biol. 193, 479–495.
Scholl, D., Kieleczawa, J., Kemp, P., Rush, J., Richardson, C.C., Merril, C.,
Adhya, S., Molineux, I.J., 2004. Genomic analysis of bacteriophages
SP6 and K1-5, an estranged subgroup of the T7 supergroup. J. Mol.
Biol. 335, 1151–1171.
Slavcev, R.A., Hayes, S., 2003. Stationary phase-like properties of the
bacteriophage E Rex exclusion phenotype. Mol. Genet. Genomics
269, 40–48.
Snyder, L., 1995. Phage-exclusion enzymes: a bonanza of biochemical and
cell biology reagents? Mol. Microbiol. 15, 415–423.
Snyder, L., Kaufmann, G., 1994. T4 phage exclusion mechanisms. In:
Karam, J.D. (Ed.), Molecular Biology of Bacteriophage T4. American
Society for Microbiology. Washington, DC, pp. 391–396.
Struhl, K., Ausubel, M.F., Brent, R., Kingston, R.E., 1992. Current Proto-
cols in Molecular Biology, vol. 2, pp. 11–42.
Studier, F.W., 1979. Relationships among different strains of T7 and among
T7-related bacteriophages. Virology 95, 70–84.
von Heijne, G., 1989. Control of topology and mode of assembly of a
polytopic membrane protein by positively charged residues. Nature
341, 456–458.
Wang, W., 1997. Isolation and characterization of E. coli fxsA, a gene that
can suppress F exclusion of bacteriophage T7. Ph. D. Dissertation.
University of Texas at Austin.
Wang, R.F., Kushner, S.R., 1991. Construction of versatile low-copy-num-
ber vectors for cloning, sequencing, and gene expression in Escherichia
coli. Gene 100, 195–199.
Wang, W., Cheng, X., Molineux, I.J., 1999a. Isolation and identification of
fxsA, an E. coli gene that can suppress F exclusion of bacteriophage T7.
J. Mol. Biol. 292, 485–499.
Wang, W., Margolin, W., Molineux, I.J., 1999b. Increased synthesis of an
E. coli membrane protein suppresses F exclusion of bacteriophage T7.
J. Mol. Biol. 292, 501–512.
Watanabe, T., Okada, M., 1964. New type of sex factor-specific bacterio-
phage of Escherichia coli. J. Bacteriol. 87, 727–736.
Wurgler, S.M., Richardson, C.C., 1990. Structure and regulation of the
dGTP triphosphohydrolase from Escherichia coli. Proc. Natl. Acad.
Sci. U.S.A. 87, 2740–2744.
Young, E.T., Menard, R.C., 1975. Analysis of the template activity of
bacteriophage T7 messenger RNAs during infection of male and female
strains of Escherichia coli. J. Mol. Biol. 99, 167–184.
Zinder, N.D., 1961. A bacteriophage specific for F Salmonella strains.
Science 133, 2069–2070.
